Skip to main content
ByMarch 11, 2026~16 min read

Israel Aerospace Industries 2025: Demand Is Proven, Cash Conversion Is the Test

Israel Aerospace Industries ended 2025 with 20.8% revenue growth and a 50.8% jump in operating profit, yet operating cash flow fell to $832 million. Defense demand is no longer the question; 2026 will be judged on whether backlog, working capital, and capital allocation finally line up.

Getting To Know The Company

Israel Aerospace Industries is not a demand-discovery story anymore. It is a state-owned defense manufacturer with four operating divisions, 87% of 2025 revenue from military activity, and 66% of revenue generated outside Israel. The real economic engine in 2025 was easy to identify: Missile & Space Systems and Elta drove growth, margins improved, and the fourth quarter was the strongest quarter of the year. That is not the problem.

The active bottleneck is the gap between profit and cash. A superficial read of the year can stop at backlog and operating profit. A better read notices that the company ended 2025 with net trade receivables of $2.34 billion, net contract assets of $1.553 billion, inventory of $1.078 billion, and operating cash flow of only $832 million, down from $2.322 billion in 2024. In other words, demand is proven, but the conversion of that demand into billings, collections, and cash is still not clean.

There is also a structural friction point that matters early in the screen. This is a bond-listed company, not an equity-listed one, and its privatization path is still open-ended. The 2020 privatization decision remains in place, but as of the report date there is no certainty regarding the timing, scale, format, or even the actual occurrence of a public share offering. So even when operating value is created, public value access does not automatically run through a tradable stock. For now it runs through credit quality, through state dividend policy, and through the open question of whether and when an equity route will exist at all.

That is exactly why 2026 matters. It is not a demand-proof year. It is a conversion-proof year. Can the company take a peak year in defense demand, with Arrow and additional government-to-government work, and turn it into a cleaner cash, balance-sheet, and capital-allocation picture?

Economic Map In One Look

Metric2025Why it matters
Revenue$7.384 billionUp 20.8% year over year
Operating profit$751 millionUp 50.8%
Net profit$712 millionUp 44.4%
Sales to Israel's Ministry of Defense$2.005 billion28% of consolidated revenue
Export share66% of revenueHeavy exposure to foreign end markets
Employees15,151Up from 14,467 in 2024
Division2025 revenue2025 operating profitBacklog at December 31, 2025
Missile & Space Systems$3,475 million$430 million$15,593 million
Military Electronics, Elta$1,792 million$223 million$6,267 million
Aviation$1,441 million$70 million$3,443 million
Military Aircraft$675 million$51 million$3,447 million
2024 vs 2025: Growth and profitability
2025 revenue mix by division

Events And Triggers

Germany and Arrow: The company’s main growth engine is no longer hidden. The Arrow 3 program for Germany, with total consideration of $3.6 billion, reached 52% completion by year-end 2025, and the company states that there was no material change in project profitability in 2024 or 2025. That matters not only because it is large, but because it extends through 2030 and sits inside an intergovernmental structure with no convenience termination clause on the German side. Then in late December 2025 the German parliament approved an additional between-states purchase of Arrow components worth about $3.1 billion, and by January 11, 2026 the company had already signed the back-to-back agreement with Israel’s Ministry of Defense. This is backlog with a better quality profile.

Another GtoG project: Beyond Germany, the company had already disclosed in August 2024 another government-to-government project, through the Ministry of Defense, worth $1.9 billion. By December 31, 2025 it was about 30% complete, the expected completion date is 2031, and the company again says there is no convenience termination clause and no material profitability change in 2025. That means the 2026 question is not whether there is enough work. The question is how efficiently that work is billed and collected.

The dividend: On December 31, 2025 the board declared a $242 million dividend, treated as the final distribution for 2024 profits, subject to Israel Government Companies Authority approval. The board based its profit test on about $1.375 billion of distributable retained earnings as of September 30, 2025 and stated that the distribution would not materially affect capital structure, leverage, covenant compliance, or solvency. But the broader picture matters more: 2025 financing cash flows already included $447 million of dividends paid. So the peak year was already serving state cash extraction before the new distribution was even approved.

Labor agreements: The 2025 and early 2026 labor timeline has to be read as an economic event, not just an HR event. March 2025 brought a temporary wage-reduction agreement for 2025 and 2026, including cuts to special profit bonuses tied to 2024 results. May 2025 brought quarterly grants, June 2025 brought the long-weekend agreement, and January 2026 brought the regularization agreement meant to address alleged wage irregularities and create a path toward a new wage model by June 2027, with a possible extension to June 2028. But the regularization agreement, like the With a Lion agreement, still lacked formal approval from the wage commissioner as of the report date. The labor cost base is therefore still in transition rather than fully reset.

The bond and reporting status: In late October 2025 the company amended the series D bond indenture, pushing the final principal payment to December 1, 2026 instead of December 1, 2025 and adding two interest payments in June and December 2026. The company explicitly says this was not driven by liquidity stress, but by a desire to preserve its status as a reporting corporation. That is an important signal: the debt market is not flagging distress, but it also underlines that the company’s public interface is still debt-centric, not equity-centric.

TriggerStatusWhy it matters
Arrow 3 for Germany52% complete at December 31, 2025Extends high-quality visibility through 2030
Additional Arrow components orderGerman approval in December 2025, back-to-back agreement in January 2026Pushes the core missile franchise beyond 2026
$242 million dividendDeclared, pending approvalA capital-allocation question, not a profit-recognition question
Regularization agreementSigned in January 2026, not yet formally approvedAffects wage framework, industrial stability, and privatization readiness
Backlog by division

Efficiency, Profitability, And Competition

The margin improvement in 2025 did not come from volume alone. It came primarily from a better mix. Missile & Space Systems increased revenue by 31% to $3.475 billion and operating profit to $430 million from $245 million in 2024. Elta grew revenue by 21% to $1.792 billion and operating profit to $223 million from $154 million. Aviation, by contrast, reached $1.441 billion of revenue with only $70 million of operating profit, a 4% margin. The consolidated margin step-up therefore reflects where growth happened, not just that growth happened.

The quarterly pattern says the same thing. Fourth-quarter 2025 revenue reached $2.247 billion, gross profit $479 million, operating profit $262 million, and net profit $228 million. That was the strongest quarter of the year across most profit lines. This does not look like a peak year that rolled over into year-end weakness. It looks like a peak year that raised the bar for 2026 execution.

The other side of the story is that the civil side of the company is structurally lower quality from a margin perspective and more dependent on external anchors. In business jets, the company explicitly states that if the Gulfstream agreement were to end, the company’s business-jet manufacturing activity could stop. That is not a group-level existential risk, but it does explain why the reader needs to separate value engines. Missiles and military electronics carried 2025. Aviation preserved scale, but it did not define the year’s earnings quality.

Customer concentration also remains real. Sales to Israel’s Ministry of Defense rose to $2.005 billion in 2025, or 28% of consolidated revenue, from $1.658 billion and 27% in 2024. Meanwhile the second major customer, which the company does not identify by name, fell to $810 million and 10% of revenue from $870 million and 14% in 2024. So concentration did not disappear. It simply tilted further toward the Israeli defense establishment, which affects both cash flow timing and export signaling.

There is also a one-sentence industry point that matters here: the Russia-Ukraine war, the Iron Swords war, and the push for higher NATO defense spending clearly support demand, but the company itself also points to local-production pressure, licensing constraints, political considerations, and supply-chain disruption. Demand is favorable. Capture conditions are less frictionless.

2025 operating profit by division
2025 by quarter: Revenue vs operating profit

Cash Flow, Debt, And Capital Structure

This is where 2026 will be judged. I am using an all-in cash view here, not a theoretical earnings-power lens. The key question for Israel Aerospace Industries right now is not whether the business is profitable. It is how much cash is left after working capital, investment, financing, and distributions.

The gap between profit and cash was wide in 2025. Net profit rose to $712 million, but net cash from operating activities fell to $832 million from $2.322 billion in 2024. The directors’ report points directly to working-capital movement as the main driver. That is not a technical footnote. It is the core issue. Net trade receivables rose to $2.34 billion from $1.271 billion. Net contract assets increased to $1.553 billion from $1.364 billion. Inventory reached $1.078 billion, and deferred expenses plus advances to suppliers rose to $602 million from $489 million. Put simply, the company is producing, selling, and earning, but too much value is still sitting between execution, milestone, invoice, collection, and stock.

The filing gives a more precise look at that mechanism. During 2025, $854 million of opening contract assets moved into receivables. So conversion is in fact occurring. But contract assets still ended the year at a higher level, $1.553 billion net, after deducting $410 million of customer advances. That is exactly the issue in a defense contractor of this scale: cash conversion exists, but the new backlog and higher execution pace rebuild the same trap as soon as it starts to clear.

The credit-day picture tells the same story. Average customer credit stood at 83 days in 2025, while average supplier credit stood at 69 days. In a normal industrial name that would not be dramatic. In a multi-year defense platform with very large contracts, it becomes a meaningful cash-absorption mechanism.

That said, this is not a distress story. The company shows adjusted working-capital surplus of $1.159 billion, a current ratio of 1.08, and a quick ratio of 0.96, and it states explicitly that it complies with all financial covenants. Utilized credit lines for guarantees stood at $2.306 billion. The final maturity of the remaining series D bond principal was pushed to December 1, 2026, and the company says that move was intended to preserve reporting status rather than to address cash stress.

One more point matters. Despite weaker operating cash flow, the company did not end the year with lower cash. Cash and cash equivalents at year-end 2025 stood at $486 million versus $217 million at the end of 2024. That happened even after $103 million of investing cash outflow and $469 million of financing outflow, including $447 million of dividends paid. So the picture is not "there is no cash." The picture is "cash exists, but it is working too hard, and part of it is still being pulled out."

Operating working capital: where the cash sits
Cash flow: Operating, investing, and financing

Forward View

Before the forward view itself, four non-obvious conclusions from the filing matter:

  • 2025 already solved the demand question. The missile franchise, Germany, and the additional GtoG work have extended multi-year visibility.
  • The margin improvement came mainly from mix, not from cleaner cash conversion.
  • The best-quality backlog sits in government programs without convenience termination clauses, especially the German Arrow thread, not automatically across the whole book.
  • Wages, dividends, and privatization are still being managed through state-company logic rather than through plain market logic.

That makes 2026 a cash-conversion proof year. Not a demand breakout year, because demand is already there, and not a reset year, because profitability clearly improved. It is a year in which the company has to prove that the operating peak of 2025 can get through the filters of working capital, distributions, and labor normalization.

The first thing that has to happen is better collections. If 2026 still shows revenue growth but receivables and contract assets start easing relative to sales, the market can begin to read 2025 as a heavy-execution year that temporarily absorbed cash. If 2026 again shows strong profits alongside rising receivables and contract assets, the thesis stays incomplete: yes on backlog, not yet on cash.

The second thing is cost-base stabilization. The company explicitly says there is no certainty that a new wage-model agreement will be signed within the expected timetable. Since the recent labor stack includes temporary wage reductions, grants, long-weekend arrangements, and a future wage-model negotiation, 2026 will test not only labor cost, but labor-cost visibility.

The third thing is backlog quality in execution. In Missile & Space Systems, backlog stood at $15.593 billion at December 31, 2025 and already reached $19.205 billion near the report date. That is a huge number. But the market will not judge size alone. It will judge the pace of revenue recognition, billing, and cash collection, and whether margins hold as those programs move into heavier execution phases.

The fourth thing is capital allocation. After $447 million of dividends paid in 2025 and another $242 million declared at year-end, 2026 has to prove that state cash extraction does not come at the expense of financing flexibility for inventory, advances, development, labor, and milestone-heavy long-cycle programs. This is not a profit-test question. It is a priority-setting question.

Another layer remains important: even if operations improve, there is still no certainty around an IPO. So it is hard to build a clean public-market story here in the way one would for a normal listed equity. Any operating improvement still has to pass two open tests: does it convert to cash, and does that cash remain in a place where public value can actually be accessed?

Risks

Working capital and customer concentration

The first risk is not falling demand. It is longer cash cycles. The company explicitly states that Israel’s Ministry of Defense is a major customer and that uncertainty around the defense budget can affect results and cash flow, including through payment timing. When 28% of sales come from that customer, this is no longer a side note.

Alongside that, there is another major customer, still unnamed, that represented 10% of 2025 revenue. That is better than 14% in 2024, but it still means diversification is not perfect. More broadly, the company highlights that contracts differ materially in milestone structure, advances, and terms. Large backlog does not automatically convert at the same cash speed.

Supply chain, licenses, and local production

The company explicitly describes halted European component supplies for defense industries, continuing supply-chain friction, longer lead times, and shortages in certain raw materials. As of the report date it says it cannot assess whether this trend will continue or how severe it could become. At the same time, many customer countries are pushing for local production, which requires partnerships, acquisitions, joint ventures, and knowledge transfer. As a government company, IAI says its own regulatory constraints make these moves slower and harder to execute.

Labor, governance, and privatization

The third risk is a triangle of labor, regulation, and governance. The regularization agreement and the With a Lion agreement still lacked formal approval as of the report date. The company also says there is no certainty that a new collective wage model will be signed within the planned timeline. Meanwhile, the privatization path still lacks a binding timetable or structure. That does not threaten 2026 order flow, but it does constrain the ability to tell a clean capital-markets story.

Civil aviation

Civil activity is not the core thesis in 2025, but it is a clear risk pocket. In business jets, the company states explicitly that if the Gulfstream agreement ends, the company’s business-jet manufacturing activity could stop. That is not a group-level existential threat, but it is a reminder that the civil segment remains more partner-dependent and less protected by the same demand environment that is driving missiles and electronics.


Conclusions

Israel Aerospace Industries enters 2026 from a position of strength. Defense demand is strong, Germany extends visibility, the fourth quarter was excellent, and the company does not read like a balance-sheet stress case. But the main bottleneck has shifted. It is no longer "is there enough work?" It is "how much of that work becomes usable cash without eroding flexibility?"

The current thesis in one line: 2025 proved that IAI can produce a peak operating year, but 2026 will be judged on whether backlog, collections, labor costs, and dividends can finally fit into the same cash picture.

What changed versus the simple read of the company: it used to be easy to read the story through backlog, exports, and flagship systems. Now it has to be read through working capital. Profitability has already improved. The open question is whether that profitability also closes the cash gap.

The strongest counter-thesis is that the concern is overstated: this is a project-heavy defense contractor, working capital is naturally lumpy, the company remains covenant-compliant, year-end cash actually improved, and the Germany and GtoG programs make 2025 look more like cyclical cash noise than structural weakness.

What can change the market read in the short to medium term is not another demand headline, but three harder things: better collections in upcoming quarters, approval and payment of the new dividend without fresh cash pressure, and a more stable and clearly approved wage framework. If all three line up, 2025 may look in hindsight like a peak year that also built a durable base. If not, it may look like a peak year that left too much cash stranded along the way.

Why this matters: the gap between a defense company with massive demand and an industrial platform that converts that demand into accessible value runs exactly through this mix of working capital, labor, and capital allocation.

MetricScoreExplanation
Overall moat strength4.5 / 5Core defense systems, deep Ministry of Defense relationship, prime-contractor position in government programs, and broad technological capability
Overall risk level3.2 / 5Not a survival risk, but a working-capital, regulatory, labor, and budget-concentration risk set
Value-chain resilienceMediumDemand is strong, but the company itself points to component dependence, licensing risk, local-production pressure, and supply-chain friction
Strategic clarityMediumDemand direction is clear, but the wage model, privatization path, and cash-conversion path remain open
Short-interest stanceNo short-interest data availableThe company is bond-listed only, so there is no relevant equity short-interest read

Disclosure: Deep TASE analyses are general informational, research, and commentary content only. They do not constitute investment advice, investment marketing, a recommendation, or an offer to buy, sell, or hold any security, and are not tailored to any reader's personal circumstances.

The author, site owner, or related parties may hold, buy, sell, or otherwise trade securities or financial instruments related to the companies discussed, before or after publication, without prior notice and without any obligation to update the analysis. Publication of an analysis should not be read as a statement that any position does or does not exist.

The analysis may contain errors, omissions, or information that changes after publication. Readers should review official filings and primary sources before making decisions.

Found an issue in this analysis?Editorial corrections and sharp feedback help keep the coverage honest.
Report a correction
Follow-ups
Additional reads that extend the main thesis